ABSTRACT
Introduction
Hepatitis B virus (HBV) infection is a major health problem, with about 5% of the world's population being chronically infected. Of these, about 1 million die each year due to progression to cirrhosis or hepatocellular carcinoma (1) . HBV is the smallest DNA virus known, and its genome shows a highly compact organization. A unique aspect in the HBV replication cycle is that pregenomic mRNA serves as a template for synthesis of the first viral DNA strand by the reverse transcriptase (RT) polymerase of HBV (2) . The RNAse H activity of the HBV DNA polymerase removes the mRNA during this process, and synthesis of the complementary second DNA strand is then started, generating a partially double-stranded DNA molecule for packaging in virions. When the virus enters the host, this molecule is extended into a fully double-stranded DNA molecule, thus starting a new replication cycle (3, 4, 5) . HBV DNA can be detected in the blood in more than 90% of infected hosts who are positive for hepatitis B surface antigen (HBsAg) and hepatitis B e antigen (HBeAg).
The use of polymerase chain reaction (PCR) in molecular diagnostics has increased to the point where it is now accepted as the golden standard for detecting nucleic acids from a number of origins and it has become an essential tool in the research laboratory. The method utilizes a pair of synthetic oligonucleotides or primers, each hybridizing to one strand of a double-stranded DNA (dsDNA) target, with the pair spanning a region that will be exponentially reproduced. The hybridized primer acts as a substrate for a DNA polymerase (most commonly derived from the thermophilic bacterium Thermus aquaticus and called Taq), which creates a complementary strand via sequential addition of deoxynucleotides. The process can be summarized in three steps: (i) dsDNA separation at temperatures > 90°C, (ii) primer annealing at 50-75°C, and (iii) optimal extension at 72-78°C (6). Traditional detection of amplified DNA relies upon electrophoresis of the nucleic acids in the presence of ethidium bromide and visual or densitometric analysis of the resulting bands after irradiation by ultraviolet light (7) . On the other hand, the Real Time PCR relies upon detection of fluorescence triggered by different mechanisms (8, 9) . In this experiment SYBR ® Green 1 was used. It is fluorophore which fluoresce when associated with dsDNA which is exposed to a suitable wavelength of light (6).
Materials and Methods
Patients and clinical samples Serum was obtained from eight patients with chronic HBV infection and cirrhosis, which were positive for both HBsAg and HBeAg. Serological determination of HBV markers was performed with commercially available ELISA kits (HBsAg Monolisa + 3.0; HBeAg Monolisa 3.0/BIO-RAD/). Extraction of HBV DNA Еxtraction of the virus DNA from the sera was made by the phenol-chloroform method (10) . A 300 µl portion of serum was incubated at 65°C for 2 hours in the presence of proteinase K, 0.2M EDTA, 1.5 M NaAc, 10% sodium dodecyl sulfate (SDS), tRNA and salmon DNA. To each sample was added equal quantity of Phenol/Isoamyl alcohol/Chloroform (25/24/1)/AppliChem/. The probes were centrifuged for 10min at 12 000 rpm (4 ºC) and the upper phase was transferred into new tubes. This procedure was repeated 3 times in order to achieve clear upper phase. Chloroform/Isoamyl alcohol (24/1) was added afterwards and the samples were centrifuged for 1min and only the clear upper layer was extracted as previously. Then, 3M NaAc and 100% ethanol was added to the samples and they were centrifuged for 20 min. The liquid phase was removed from the tubes and 70% ethanol was added. After 5 min centrifugation the ethanol was removed and the samples were dried for about 40min. To the dried samples 20 µl of sterile water was added and the samples were left overnight at 4°C.
Polimerase Chain Reaction (PCR)
In-house PCR The serum DNA sample (2 µl) was amplified in a 50 µl reaction volume containing primers Hbv-1 and Hbv-2 -2 µl each, Reaction Buffer -5 µl, MgCl -3 µl, dNTP`s -4 µl, Taq-P -0,25 µl, and sterile water -31,75 µl. The reaction was performed in a programmable DNA MiniCycler™ (MJ Research, USA) by the following protocol: 5 min. at 94°C; 1min. at 94°C; 1min. at 45°C; 2 min. at 72°C. The last three steps were repeated 35 times and were followed by the last step -10 min. at 72°C. 10 µl of each amplified sample was fractionated by 1% agarose gel electrophoresis and visualized by UV fluorescence after staining with ethidium bromide.
Real Time PCR
The same primers were used. The extracted serum DNA (10 µl) was added to a Master Mix containing 1 µl of each primer, 25 µl of SYBR ® Green I (Invitrogen™) and 13 µl sterile water. The reaction volume was 50 µl. The reaction was performed following the protocol: 10 min. at 95°C; 15 sec. at 95°C; 30 sec. at 55°C; 30 sec. at 72°C. The last three steps were repeated for 45 times and at the end melting curve analysis was made between 55°C-95°C. The last step was 10 min. at 72°C. The Real Time PCR was performed using DNA Engine Opticon™ Version 1.0 (MJ Research, USA).
In both experiments along with the patient sera, an HBV DNA standard 10 3 IU/ µl was used for comparison with the results.
Results and Discussion
In the first experiment (in-house PCR) was found that all of the tested patients were positive for HBV DNA. The results were shown by agarose gel electrophoresis. The results from the second experiment confirmed the data from the first experimentall the sera were positive for HBV DNA. The Melting curve analysis was performed and it was shown that the curves of the sera were almost identical with the curve of the positive HBV 10 3 IU/µl standard ( Fig. 1  and Fig. 2) . For clearer image the graphic of the Melting curve analysis was divided into two separate tables - Fig. 1 shows the first five sera, and Fig. 2 shows sera № 6, 7, 8, 10 and the standard as № 9.
After comparison of the two PCR techniques it was shown in this case that both of them are accurate and reliable. It has been suggested that in-house PCR assays often suffer from problems with standardization, false positive results, or contamination (11) . Sample preparation is still the most difficult step to perform and to automate for both commercial and in-house assays and complete abolishment of postamplification handling is an additional factor in limiting contamination. The Real Time PCR has several advantages, which makes it more useful in the practice:
The time needed to complete the amplification protocol by in-house method for detection of HBV DNA is longer (3 h) compared with the time that Real Time PCR technology consumes (1,45 h) but the last method is more sensitive, being able to detect less than 100 HBV DNA copies/ml.
The Real Time technique enables to be distinguished the wild type HBV and mutations in the viral genome by the changes in DNA thermal stability, which results in a different melting curve. It is important to monitor this process because of the emergence of drug resistant HBV strains carrying mutations associated with the treatment (12, 13) .
The technique reduces the risk of contamination and false positive results and there is not direct exposure to any toxic substances. The amount of PCR product amplified is monitored in each cycle and the method provides rapid analyses of absolute template amounts without post-PCR step.
In conclusion, the real-time PCR with SYBR ® Green I for detecting HBV DNA is accurate, rapid and highly reproducible assay.
